Hefei Lifeon Pharmaceutical Co., Ltd.
SZSE:003020 Rapporto sulle azioni
Hefei Lifeon Pharmaceutical Salute del bilancio
Salute finanziaria criteri di controllo 6/6 Hefei Lifeon Pharmaceutical ha un patrimonio netto totale di CN¥1.9B e un debito totale di CN¥59.6M, che porta il suo rapporto debito/patrimonio netto a 3.1%. Le sue attività totali e le sue passività totali sono rispettivamente CN¥2.6B e CN¥630.2M. L'EBIT di Hefei Lifeon Pharmaceutical è CN¥166.7M rendendo il suo rapporto di copertura degli interessi -18. Ha liquidità e investimenti a breve termine pari a CN¥487.6M.
Informazioni chiave
3.1%
Rapporto debito/patrimonio netto
Indice di copertura degli interessi -18x Contanti CN¥487.65m Patrimonio netto CN¥1.92b Totale passività CN¥630.16m Totale attività CN¥2.55b
Aggiornamenti recenti sulla salute finanziaria
Mostra tutti gli aggiornamenti
Why Hefei Lifeon Pharmaceutical's (SZSE:003020) Shaky Earnings Are Just The Beginning Of Its Problems Nov 05
Third quarter 2024 earnings released: EPS: CN¥0.23 (vs CN¥0.22 in 3Q 2023) Oct 30
Hefei Lifeon Pharmaceutical (SZSE:003020) Has A Somewhat Strained Balance Sheet Sep 30
Hefei Lifeon Pharmaceutical Co., Ltd. to Report Q3, 2024 Results on Oct 30, 2024 Sep 30
Investor sentiment improves as stock rises 19% Sep 30
Second quarter 2024 earnings released: EPS: CN¥0.24 (vs CN¥0.34 in 2Q 2023) Aug 31
Hefei Lifeon Pharmaceutical Co., Ltd. to Report First Half, 2024 Results on Aug 31, 2024 Jun 29
Hefei Lifeon Pharmaceutical (SZSE:003020) Has Announced A Dividend Of CN¥0.50 May 23
Dividend of CN¥0.50 announced May 23
Investors Still Aren't Entirely Convinced By Hefei Lifeon Pharmaceutical Co., Ltd.'s (SZSE:003020) Earnings Despite 25% Price Jump May 22
Hefei Lifeon Pharmaceutical's (SZSE:003020) Profits May Not Reveal Underlying Issues Apr 29
Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Apr 24
Hefei Lifeon Pharmaceutical Co., Ltd., Annual General Meeting, May 14, 2024 Apr 23
Investor sentiment improves as stock rises 16% Apr 23
Hefei Lifeon Pharmaceutical Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024 Mar 30
Investor sentiment deteriorates as stock falls 18% Feb 02
Hefei Lifeon Pharmaceutical Co., Ltd. to Report Fiscal Year 2023 Results on Apr 23, 2024 Dec 29
Hefei Lifeon Pharmaceutical Co., Ltd. Approves Election of Shi Jing as an Independent Director Nov 18
Third quarter 2023 earnings released: EPS: CN¥0.27 (vs CN¥0.46 in 3Q 2022) Nov 01
Investor sentiment improves as stock rises 18% Oct 30
New minor risk - Share price stability Oct 23
Hefei Lifeon Pharmaceutical Co., Ltd. to Report Q3, 2023 Results on Oct 31, 2023 Sep 30
Second quarter 2023 earnings released: EPS: CN¥0.41 (vs CN¥0.33 in 2Q 2022) Aug 29
Investor sentiment deteriorates as stock falls 16% Aug 03
Hefei Lifeon Pharmaceutical Co., Ltd. Declares Cash Dividend on A Shares for 2022, Payable on May 24, 2023 May 18
Hefei Lifeon Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023 May 12
First quarter 2023 earnings released: EPS: CN¥0.54 (vs CN¥0.39 in 1Q 2022) Apr 18
Investor sentiment improves as stock rises 18% Feb 28
Third quarter 2022 earnings released: EPS: CN¥0.59 (vs CN¥0.35 in 3Q 2021) Oct 31
Investor sentiment improved over the past week Oct 18
Hefei Lifeon Pharmaceutical Co., Ltd. Announces Board Appointments Sep 01
Second quarter 2022 earnings released: EPS: CN¥0.43 (vs CN¥0.35 in 2Q 2021) Aug 29
Hefei Lifeon Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2021R May 17
Hefei Lifeon Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2021 May 12
First quarter 2022 earnings released: EPS: CN¥0.51 (vs CN¥0.45 in 1Q 2021) Apr 29
No independent directors Apr 27
Hefei Lifeon Pharmaceutical Co. Proposes Final Cash Dividend for 2021 Apr 20
Full year 2021 earnings released: EPS: CN¥1.86 (vs CN¥1.94 in FY 2020) Apr 19
Third quarter 2021 earnings released: EPS CN¥0.45 (vs CN¥0.49 in 3Q 2020) Oct 26
Second quarter 2021 earnings released: EPS CN¥0.45 (vs CN¥0.53 in 2Q 2020) Aug 18
Investor sentiment deteriorated over the past week Jul 27
Investor sentiment improved over the past week Jun 02
Investor sentiment improved over the past week May 18
Hefei Lifeon Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2020 May 14
First quarter 2021 earnings released: EPS CN¥0.45 (vs CN¥0.47 in 1Q 2020) Apr 28
Full year 2020 earnings released: EPS CN¥1.94 (vs CN¥1.51 in FY 2019) Apr 09
Hefei Lifeon Pharmaceutical Co., Ltd. to Report Fiscal Year 2020 Results on Apr 09, 2021 Feb 24
Investor sentiment deteriorated over the past week Jan 13
Investor sentiment deteriorated over the past week Dec 25
Analisi della posizione finanziaria
Passività a breve termine: Le attività a breve termine ( CN¥1.2B ) di 003020 superano le sue passività a breve termine ( CN¥537.8M ).
Passività a lungo termine: Le attività a breve termine di 003020 ( CN¥1.2B ) superano le sue passività a lungo termine ( CN¥92.4M ).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: 003020 ha più liquidità del suo debito totale.
Riduzione del debito: Il rapporto debito/patrimonio netto di 003020 si è ridotto da 4.7% a 3.1% negli ultimi 5 anni.
Copertura del debito: Il debito di 003020 è ben coperto dal flusso di cassa operativo ( 449.9% ).
Copertura degli interessi: 003020 matura più interessi di quanti ne paga, quindi la copertura dei pagamenti degli interessi non è un problema.
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
